Nov 16, 2020 | Press Releases
Company to Provide Investor Update on November 19 at 4:30pm ET (Details Below)SARASOTA, Fla., Nov. 16, 2020 — INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...
Sep 30, 2020 | Press Releases
Joint Venture Targets the Large and Growing Mexico Market for Infertility ServicesSARASOTA, Fla., Sept. 30, 2020 – INVO Bioscience, Inc. (OTCQB: INVO) developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, announced today...
Sep 16, 2020 | Press Releases
INVO’s Board strengthened with independent directors as we enter a new growth trajectory for the CompanySARASOTA, Fla., Sept. 16, 2020 — INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients...
Aug 13, 2020 | Press Releases
Company to Provide Investor Update During Virtual Investor Conference on August 19 at 2:00pm ET (Details Below); Management Available for Virtual 1×1 MeetingsSARASOTA, Fla., Aug. 13, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), a medical device company...
Aug 6, 2020 | Press Releases
SARASOTA, Fla., Aug. 6, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), (“the Company”, “INVO”) a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
Jul 16, 2020 | Press Releases
– An estimated 15% to 20% of the Turkish population suffers from the difficulty of conceiving- “As the world’s only Intravaginal Culture System, INVOcell, a streamlined treatment solution, is uniquely positioned to address the challenges within the...
